The below post is a copy of the news release published by the Canadian Cancer Society at https://bit.ly/2E83hbF A Canadian Cancer Society (CCS)-funded study has found that, unless Canada makes changes, excess weight will become the second leading preventable cause of cancer, following tobacco. The Canadian Population Attributable Risk of Cancer (more…)
Special supplement on Canadian cancer costing research ARCC is pleased to have partnered with the Ontario Institute for Cancer Research on a special supplement of Canadian cancer costing research, published today in Current Oncology. From ARCC’s Commentary: “As we approach the 10th anniversary of the Canadian Centre for Applied Research in (more…)
The Canadian Centre for Applied Research in Cancer Control (ARCC) is proud to announce that the Dalhousie Medical Research Foundation (DMRF) has awarded a Conference Grant in support of the 2019 ARCC Conference, being held May 27-28, 2019, at the Halifax Convention Centre. The DMRF grant application was co-supported by Dalhousie (more…)
The Biostatistics Research Unit (BRU) in partnership with the Toronto Health Economics and Technology Assessment (THETA) Collaborative will be hosting a series of short courses on R. R is a powerful and flexible software environment for statistical analysis and graphics. R is freely available, facilitating analysis and model transparency and reproducibility. (more…)
Mark your calendars for the Canadian Cancer Research Conference taking place November 3 to 5, 2019 in Ottawa, Ontario. Hosted by the Canadian Cancer Research Alliance, this three-day event brings together researchers, clinicians, decision-makers, and trainees at all stages of their career. Abstract Submission for the 2019 CCRC will open (more…)
CANADA RESEARCH CHAIR TIER 2, HEALTH ECONOMICS POSTED: March 11, 2019, Department of Community Health Sciences, Max Rady College of Medicine, Rady Faculty of Health Sciences Position Numbers 27187 and 27816. The University of Manitoba invites applications for a Tier 2 Canada Research Chair, a tenured or tenure-track position at (more…)
Bench to Bedside Translation of Innovative Cancer Biotherapeutics BioCanRx, Canada’s Immunotherapy Network, is pleased to announce its 2019 Call for Letters of Intent. Selected Letters of Intent will be featured in the Scientific Program of our Cycle II application going forward for review in July 2019 to the federal government’s (more…)
CADTH has released a Call for Nominations for its advisory and expert committees. This is an exciting opportunity for those interested in supporting health care decision-makers to make informed choices about health technologies. The nomination process runs to Friday, April 26, 2019. We are seeking the following role to sit (more…)
Connect With Us!